2-(1-Naphthylmethylidene)succinic Acid | 125702-08-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-(1-Naphthylmethylidene)succinic Acid
• 英文别名: 2-(Naphthalen-1-ylmethylene)succinic acid；(2Z)-2-(naphthalen-1-ylmethylidene)butanedioic acid
• CAS: 125702-08-1
• 化学式: C₁₅H₁₂O₄
• 分子量: 256.258
• InChiKey: OCEJTXWZGWBSPX-WQLSENKSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(1-Naphthylmethylidene)succinic Acid 在 palladium on activated charcoal 叠氮磷酸二苯酯 、 氢气 、 乙酸酐 、 三乙胺 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 Nα-[3-Morpholinocarbonyl-2-(1-naphthylmethyl)propionyl]-L-histidine methyl ester
  参考文献：
  名称：

  新型人类肾素抑制剂，含有一种非天然氨基酸降冰片stat。

  摘要：

  DOI：

  10.1021/jm00399a001
• 作为产物：
  描述：

  1-萘甲醛 在 sodium hydroxide 、 sodium methylate 作用下， 反应 4.0h， 生成 2-(1-Naphthylmethylidene)succinic Acid
  参考文献：
  名称：

  包含新型氨基酸环己基去甲他汀的口服强效人肾素抑制剂的设计与合成

  摘要：

  从血管紧张素原过渡态设计并合成了一种口服有效的人肾素抑制剂（1a），其中含有一种新型氨基酸（2 R，3 S）-3-氨基-4-环己基-2-羟基丁酸，称为环己基去甲他汀。

  DOI：

  10.1039/c39890001678

文献信息

• Novel amino acid derivatives possessing renin-inhibitory activities
  申请人：Japan Tobacco Inc.

  公开号：EP0396065A1

  公开（公告）日：1990-11-07

  An amino acid derivative of the general formula: wherein R1 is wherein, R10 is a lower alkyl group and R" is (wherein R111 is a lower alkyl group and n is an integer of 1 to 5) or a lower alkyl group which may be substituted by hydroxy group or methoxyethoxymethoxy group, or R'° and R" are combinedly together with the adjacent nitrogen atom; R12 is a hydrogen atom, CnH2n+1-O-CO- (n is as defined above) or R'3 is a lower alkyl group which may be substituted by substituent(s) selected from HOOC-(H2C)n-O-, R12- NH- (n and R12 are as defined above) and pyridyl group; X is -CH2-, -O- or -NH- and Y is -O- or -NH-; wherein (wherein Z is -0-, -S-, -S(O)-. -S(O)2-, -CH2-, -CH(OH)-, or and a and b are independently an integer of 1 to 4 and the total of a and b is not more than 5) ; R2 is an aralkyl group which may be substituted by lower alkyl group(s); R3 is a hydrogen atom or a lower alkyl group; R4 is a lower alkyl group; and A is hydroxy group and B is a hydrogen atom, or A and B are carbonyl group combinedly together with the adjacent carbon atom, a pharmaceutically acceptable acid addition salt or an ester thereof is described. The compounds of the invention possess inhibitory activities against renin and are useful as an antihypertensive agent.

  通用公式的氨基酸衍生物： 其中R1为 其中，R10为较低的烷基基团，R"为 （其中R111为较低的烷基基团，n为1至5的整数）或者可以被羟基或甲氧乙氧甲氧基取代的较低烷基基团，或者R'°和R"与相邻的氮原子 结合在一起； R12为氢原子，CnH2n+1-O-CO-（n如上定义）或者 R'3为可以被HOOC-(H2C)n-O-、R12-NH-（n和R12如上定义）和吡啶基取代的较低烷基基团； X为-CH2-、-O-或-NH-，Y为-O-或-NH-；其中 （其中Z为-0-、-S-、-S(O)-、-S(O)2-、- -、-CH(OH)-， 或 a和b分别独立为1至4的整数，且a和b的总和不超过5）； R2为可以被较低烷基基团取代的芳基烷基基团； R3为氢原子或较低烷基基团； R4为较低烷基基团； A为羟基，B为氢原子，或者A和B与相邻的碳原子结合在一起，描述了一种药学上可接受的酸盐或其酯。本发明的化合物具有对肾素的抑制活性，并可用作降压药。
• Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a Retro-inverso amide bond.
  作者：Hiromu HARADA、Kinji IIZUKA、Tetsuhide KAMIJO、Kenji AKAHANE、Ryoji YAMAMOTO、Yasushi NAKANO、Atsushi TSUBAKI、Tetsuhiro KUBOTA、Iwao SHIMAOKA、Hideaki UMEYAMA、Yoshiaki KISO

  DOI：10.1248/cpb.38.3042

  日期：——

  The experimental details for the synthesis of human renin inhibitors are described. In order to aviod metabolic degradation of the Phe-His (P3-P2) amide bond in transition-state analogs, structurally modified acyl residues (P4-P3) were incorporated into the inhibitors. Compound 1a, which contained 2-(1-naphthylmethyl)-3-(N-phenethylcarbamoyl)propionyl residue (P4-P3) with a retro-inverso amide bond, L-histidine, and norstatine isoamylamide residue (P1-P1') as a transition-state mimic, had potent human renin inhibitory activity, and it lowered blood pressure when administered orally to common marmosets.

  人肾素抑制剂的合成实验细节如下所述。为了防止过渡态类似物中Phe-His (P3-P2)酰胺键的代谢降解，抑制剂中融入了结构改良的酰基残基 (P4-P3)。化合物1a包含2-(1-萘甲基)-3-(N-苯乙基氨基甲酰)丙酰基残基 (P4-P3)，具有逆向内酰胺键，L-组氨酸和诺丝他汀异戊酰胺残基 (P1-P1') 作为过渡态模拟结构，显示出强大的人肾素抑制活性，并通过口服给药降低了普通狨猴的血压。
• Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction
  作者：Kinji Iizuka、Tetsuhide Kamijo、Hiromu Harada、Kenji Akahane、Tetsuhiro Kubota、Hideaki Umeyama、Toshimasa Ishida、Yoshiaki Kiso

  DOI：10.1021/jm00172a005

  日期：1990.10

  (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutyric acid, named cyclohexylnorstatine (2a). The optically pure cyclohexylnorstatine was efficiently prepared from Boc-L-cyclohexylalaninol (3), and the stereochemistry of 1a was established by X-ray crystal analysis. The analyses of interaction between 1a and human renin using modeling techniques indicated that (1) the cyclohexyl group of P1 and the naphthyl

  为了合理设计有效的人肾素抑制剂，推导了人肾素复合物和血管紧张素原P1'Val的易裂位点P4 Pro的三维结构。基于这种结构，从血管紧张素原过渡态设计并合成了一种口服有效的人肾素抑制剂（1a）。抑制剂1a包含一个（2R）-3-（吗啉代羰基）-2-（1-萘基甲基）丙酰基残基（P4-P3），具有逆反酰胺键，L-组氨酸和一个新氨基酸（2R， 3S）-3-氨基-4-环己基-2-羟基丁酸，称为环己基去甲他汀（2a）。由Boc-L-环己基丙氨酸（3）有效地制备了光学纯的环己基去甲他汀，并通过X射线晶体分析确定了1a的立体化学。使用建模技术分析1a与人肾素之间的相互作用表明：（1）P1的环己基和P3的萘基分别容纳在较大的疏水性亚位点S1和S3中；（2）将P2 His的咪唑氢键合到Ser-233的侧链OH上，有助于抑制肾素。（3）将环己基去甲他汀异丙酯残基容纳在S1-S1'中。清楚地表明了立体化学在有效和特
• New human renin inhibitory peptides. Angiotensinogen transition-state analogues containing novel Leu-Val replacement and a retro-inverso amide bond.
  作者：Kinji Iizuka、Tetsuhide Kamijo、Hiromu Harada、Kenji Akahane、Tetsuhiro Kubota、Iwao Shimaoka、Hideaki Umeyama、Yoshiaki Kiso

  DOI：10.1248/cpb.36.2278

  日期：——

  New human renin inhibitors were designed from transition-state analogues of angiotensinogen, synthesized and evaluated. The peptide derovative, which contained 1-naphthylmethylsuccinylamide residue (P3) with a retro-inverso amide bond and a norstatine isoamylamide residue (P1-P1'), was stable to proteases and had potent human renin inhibitory activity. This compact inhibitor exhibited hypotension when administered orally to a monkey.

  新的人类肾素抑制剂通过血管紧张素原的过渡态类似物进行设计，经合成和评估。该肽衍生物包含1-萘甲基琥珀酰亚胺残基（P3）与反向逆序酰胺键和诺斯他汀异戊酰胺残基（P1-P1'），对蛋白酶稳定且具有强大的人类肾素抑制活性。这种紧凑的抑制剂在给猴口服时表现出降压效果。
• Histidine derivatives as renin inhibitors
  申请人：Kissei Pharmaceutical Co Ltd

  公开号：EP0181110A2

  公开（公告）日：1986-05-14

  @ Dipeptides are described which are represented by the formula wherein His represents an L-histidyl group, Ar, represents a phenyl group, a naphthyl group or an indolyl group, Ar2 represents a phenyl group or a naphthyl group, X represents a chemical bond, -NHCO-, -CONH-, -CO-, -CH2-, -NH-, -O- or -(CH=CH)P-wherein p is 1 or 2, Z represents an oxygen atom or in which R2 represents a hydrogen atom or combines with R, to form a chemical bond, m and n, which may be the same or different, each represents an integer of from 0 to 3, provided that when X is a chemical bond, the sum of n plus m is from 1 to 6 and when X is not a chemical bond, the sum of n plus m is from 1 to 4, Y represents a chemical bond when X is not a chemical bond, or, when X is a chemical bond, an alkylene group having 1 to 3 carbon atoms, R1 represents a hydrogen atom or combines with R2 to form a chemical bond, R3 represents a formyl group or a hydroxymethyl group, R4 represents an isobutyl group or a benzyl group, and C represents an L-configurational carbon atom; or the pharmaceutically acceptable salt thereof. These compounds have a strong inhibitory effect on human renin, and are useful as a therapeutically active agent for the treatment of hypertension, especially renin - associated hypertension.

  @ 描述了由式表示的二肽 其中 His 代表 L-组氨酰基，Ar 代表苯基、萘基或吲哚基，Ar2 代表苯基或萘基，X 代表化学键、-NHCO-、-CONH-、-CO-、-CH2-、-NH-、-O-或-(CH=CH)P-其中 p 为 1 或 2，Z 代表氧原子或 其中 R2 代表氢原子或与 R 结合形成化学键，m 和 n 可以相同或不同，各代表 0 至 3 的整数，但当 X 为化学键时，n 加 m 之和为 1 至 6，当 X 不是化学键时，n 加 m 之和为 1 至 4、当 X 不是化学键时，Y 代表化学键；当 X 是化学键时，Y 代表具有 1 至 3 个碳原子的亚烷基；R1 代表氢原子或与 R2 结合形成化学键；R3 代表甲酰基或羟甲基；R4 代表异丁基或苄基；C 代表 L 构型碳原子；或其药学上可接受的盐。 这些化合物对人体肾素有很强的抑制作用，可作为治疗高血压，特别是肾素相关性高血压的治疗活性剂。